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ABSTRACT
Age-related dysregulated inflammation plays an essential role as a major risk 
factor underlying the pathophysiological aging process. To better understand how 
inflammatory processes are related to aging at the molecular level, we sequenced the 
transcriptome of young and aged rat kidney using RNA-Seq to detect known genes, 
novel genes, and alternative splicing events that are differentially expressed. By 
comparing young (6 months of age) and old (25 months of age) rats, we detected 722 
up-regulated genes and 111 down-regulated genes. In the aged rats, we found 32 
novel genes and 107 alternatively spliced genes. Notably, 6.6% of the up-regulated 
genes were related to inflammation (P < 2.2 × 10-16, Fisher exact t-test); 15.6% 
were novel genes with functional protein domains (P = 1.4 × 10-5); and 6.5% were 
genes showing alternative splicing events (P = 3.3 × 10-4). Based on the results of 
pathway analysis, we detected the involvement of inflammation-related pathways 
such as cytokines (P = 4.4 × 10-16), which were found up-regulated in the aged rats. 
Furthermore, an up-regulated inflammatory gene analysis identified the involvement 
of transcription factors, such as STAT4, EGR1, and FOSL1, which regulate cancer 
as well as inflammation in aging processes. Thus, RNA changes in these pathways 
support their involvement in the pro-inflammatory status during aging. We propose 
that whole RNA-Seq is a useful tool to identify novel genes and alternative splicing 
events by documenting broadly implicated inflammation-related genes involved in 
aging processes. 
INTRODUCTION
It has been established that chronic inflammation 
plays a major role in oxidative stress-induced aging 
and aging-related diseases [1]. Inflammatory processes 
activated by oxidation are known to produce reactive 
oxygen species (ROS) that inflict not only oxidative 
damage, but also elicit the release of additional 
omnipotent cytokines and chemokines, perpetuating the 
cycle and resulting in a chronic inflammatory condition 
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during aging, as predicted by molecular inflammation [2, 
3] and inflammaging [4, 5]. Chronic inflammation can 
also result from a disrupted redox balance and weakened 
anti-oxidative defense system, leading to the activation of 
redox-sensitive pro-inflammatory transcription factors, 
such as NF-κB, during aging [6]. Thus, the aging process 
is exacerbated by the up-regulation of interleukin (IL)-1β, 
tumor necrosis factor (TNF)-α, cyclooxygenase (COX), 
and inducible nitric oxide synthase (iNOS), resulting in 
an organism’s vulnerability to an age-related inflammatory 
status [7]. Although previous studies have revealed 
possible links between inflammation and aging, there 
have been no genomic scale evidence for the interaction 
between specific inflammation pathways and the aging 
process.
A number of cDNA microarray studies have been 
carried out in mammals, including mice, rats, and humans, 
to gain an understanding of the transcriptome during the 
aging process [8, 9]. Microarrays are powerful tools 
for analyzing gene expression and have increased our 
understanding of the intricate biology involved in normal 
and diseased organisms. In addition, cDNA microarray 
technology has been used to identify age-related changes 
in key pathways, such as inflammatory and mitochondrial 
processes [8-10]. However, they have inherent limitations, 
including the lack of sensitivity to low abundance 
transcripts and difficulty in detecting alternative splicing 
variants and novel transcripts [11, 12]. The capability to 
detect low abundance transcripts is important, since most 
gene transcripts are present in low quantities [13, 14]. It 
is also important to identify novel RNAs, including non-
coding RNAs [15, 16]. 
Here, we utilized advanced RNA sequencing (RNA-
Seq) based on next-generation sequencing technology 
[17]. Using RNA-Seq, we examined age-related 
differential gene expression of the rat kidney genome. 
Two experimental groups (six rats in each group) were 
compared for gene expression levels in aged rats. In 
addition, novel genes and alternative splicing of mRNAs 
in aged rats were investigated. We then analyzed gene 
sets such as differentially expressed genes. We identified 
the changes and effects of genes related to inflammation 
in global gene transcription, as well as novel genes and 
alternative splicing events during the aging process.
RESULTS
Detection of altered gene expression and 
inflammation genes in young and aged rats
We generated 7.3 billion 99-bp paired-end reads 
from 12 rats (six young Ad libitum (AL), six aged AL) 
(Figure 1A). Using readings from both TopHat [18] 
and cufflink [19], 73% of the total RNA reads were 
successfully mapped to the rat reference genome (NCBI 
build 5). By comparing against the current NCBI genome 
annotation, 31,506 known transcripts, spanning a total of 
74 Mb, were identified. More than 0.35% of the genes 
did not match to the rat genome. Based on the expression 
levels of known genes, we identified 722 up- and 111 
down-regulated genes that were changed by 2-fold or 
more (false discovery rate (FDR) < 0.05) (Figure 1B and 
Table S2).
To examine the effect of inflammation on aging 
in terms of RNA expression, we tested the statistical 
significance of genes related to inflammation in the up-
regulated genes in the old rats. 48 genes were found to be 
statistically significantly related to inflammation (6.6%) 
(P < 2.2 × 10-16, Fisher’s exact test). Genes related to 
inflammation were assigned to the ‘inflammation response’ 
of gene ontology (GO).
Identification of pathways involving differentially 
expressed genes
To classify genes in aged transcriptomes, we 
analyzed predefined biological pathways involving genes 
that significantly differed between aged and young rats 
in the gene set enrichment analysis [20]. Representative 
terms for biological pathways were used in the context of 
the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
(http://www.genome.ad.jp). In KEGG terminologies, 20 
pathways involved up-regulated genes, while 11 pathways 
involved down-regulated genes under the filtering option 
with a P < 0.01 and FDR < 0.05 (Table S3). 
In the aged rats, most of the up-regulated genes 
were involved in inflammation-related pathways, 
including cytokine and cytokine-receptor interaction, 
primary immunodeficiency, chemokine signaling, and 
T-cell and B-cell receptor signaling. In contrast, genes 
involved in various metabolism and biosynthesis pathways 
showed marked down-regulation, including glyoxylate 
and dicarboxylate metabolism, pyruvate metabolism, 
steroid biosynthesis, and drug metabolism (Figure 2). 
Because the gene set enrichment test depends on gene 
sets, we evaluated various pathway terms using BioCarta 
and Reactome as well as the KEGG pathway. In other 
databases, most genes involved in energy metabolism 
show decrease, while most of the inflammation-related 
pathway genes increase with age.
Transcription factors involved in the regulation of 
both inflammation and cancer 
To identify regulatory molecules of up-regulated 
genes using the gene set enrichment test (Table 1), 
we conducted transcription factor analysis using the 
TRANSFAC database [21]. We found that 84 transcription 
factors were present at the transcriptional start site (TSS) 
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of up-regulated genes, except transcription factors of 
down-regulated genes, which included 428 transcription 
factors. In contrast, only three transcription factors were 
identified in the TSS of down-regulated genes (Figure 
1C and Table S4). Among the transcription factors of 
up-regulated genes, we found 84 transcription factors 
including well-known age-related transcription factors 
such as hypoxia-inducible factor 1 alpha (HIF1α) and 
NFKB2. Additionally, peroxisome proliferator-activated 
receptor delta (PPARδ) was identified as a transcription 
factor of down-regulated genes.
We performed a modified gene set enrichment test 
(see Methods) to classify the 84 transcription factors 
into their appropriate pathways. Interestingly, many 
transcription factors of up-regulated genes were involved 
in cancer or inflammation pathways; pathway in cancer 
(P = 9.0 × 10-5), JAK-STAT signaling pathway (P = 4.1 
× 10-5), chemokine pathway (P = 7.1 × 10-5), and Toll-
like receptor (TLR) signaling pathway (P = 5.2 × 10-3). 
Moreover, we found that EGR1 (2.4-fold) and FOSL1 
Figure 1: Experimental design and differentially expressed genes with aging. A. To investigate the molecular basis of aging 
at the genomic level, we utilized RNA-Seq technology based on Illumina Hiseq-2000. We generated 7.3 billion 99-bp paired-end reads 
from 12 rats (six young AL, six aged AL). A total of 73% of all reads were successfully mapped on the rat reference genome of NCBI 
build 5 using both TopHat and Cufflink programs. B. Based on the expression levels of known genes, we identified 722 up-regulated and 
111 down-regulated genes that were changed by more than 2-fold (FDR < 0.05) in known genes. We carefully analyzed sequences of 
novel genes using NCBI NT and the domain database after removing non-coding RNA, and found that out of the 322 novel candidates 
with homologous genes in the NT database, only 32 novel genes had functional domains. The novel genes changed differentially by more 
than 2-fold. Using the Cufflink program, we selected 108 genes with alternative splicing events that had increased by more than 2-fold 
by comparing transcripts of young and aged rats. Interestingly, 48 known genes (6.6%), 5 novel genes (15.6%), and 7 genes (6.5%) with 
alternative splicing events were related to inflammation, showing statistically significant scores (P < 0.001, Fisher’s exact test). Genes 
related to inflammation were assigned to ‘inflammation response’ of gene ontology. C. To identify regulatory molecules of up-regulated 
genes (Table 1), we analyzed transcription factors using the TRANSFAC database. We found 84 transcription factors that existed in 
transcriptional start site (TSS) of up-regulated genes, except transcription factors of down-regulated genes among the 428 transcription 
factors. In contrast, 3 transcription factors existed only in the TSS of down-regulated genes. The red circle represents transcription factors 
that existed in the transcriptional start site of up-regulated genes. The green circle represents transcription factors of down-regulated genes. 
Detailed information is described in Table S4.
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(4.2-fold), which are involved in both HRAS-related 
oncogenic pathways [22] and inflammatory responses by 
LPS [23], were up-regulated with aging.
Up-regulation of Toll-like receptor signaling 
leading to inflammation
Based on gene set enrichment results of transcription 
factors, we analyzed the expression of genes and 
pathways. We found that TLR family and TLR signaling-
related genes were up-regulated during aging (Figure 3 
and Figure S1). TLRs are well-known membrane proteins 
that play a key role in the innate immune system, including 
the processes of inflammation and antiviral immune 
responses. 
In the TLR signaling pathway, TLR1-9 proteins 
are up-regulated during aging, although only TLR7 (3.5-
fold) and TLR8 (3.2-fold) showed statistically significant 
p-values, which were calculated by the Cuffdiff program 
(see Methods). Up-regulation of NF-κB and FOS/JUN 
through TLR2 (2.3-fold) and TLR4 (2.1-fold) induced 
up-regulation of inflammation-related genes, which 
function in the pro-inflammation effect (IL-1β, IL-6, IL-
12, and TNF-α), chemotactic genes (CCL3 and CD5), and 
T-cell stimulation-related genes (CD40, CD80, CD86, 
Figure 2: Gene set enrichment analysis of up- and down-regulated genes. Classification of the up- (722) and down- (111) 
regulated genes during aging in the context of KEGG terminologies. The mapping terminologies (pathways) were selected by Fisher’s exact 
t-test and false discovery rate (filtering options: P < 0.01 and FDR < 0.05). Red bars indicate up-regulated gene sets and green bars represent 
down-regulated gene sets in each condition. Y bar indicates the modified significant value that was calculated based on the following 
equation: abs(−log(p-value)). Each graph indicates the distribution of differentially changed genes with respect to the biological process.
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CXCL9, CXCL10, and CXCL11). These data support 
that pro-inflammation genes, cytokines, and chemokines 
are overexpressed through TLRs in aged rats, leading to 
chronic inflammation. We describe the expression of genes 
related to the TLR signaling pathways in Table S5.
Detection of altered arachidonic acid metabolism 
related to inflammation
Arachidonic acid metabolism has important roles in 
physiological and pathological processes, including host 
defense [24], renal disease [25], inflammation [26], and 
Figure 3: Toll-like receptor signaling pathway changed during aging. Based on the gene set enrichment result of up-regulated 
genes during aging, we analyzed the integrated expression of genes and pathways. We found that the Toll-like receptors (TLRs) family and 
TLR signaling-related genes were up-regulated during aging. Up-regulation of NF-κB and FOS/JUN through TLR2 (2.3-fold) and TLR4 
(2.1-fold) was observed for up-regulation of inflammation-related genes that function in the pro-inflammation effect (IL-1β, IL-6, IL-12, 
and TNFα) and chemotactic genes (CCL3 and CD5), as well as T-cell stimulation related genes (CD40, CD80, CD86, CXCL9, CXCL10, 
and CXCL11). These data support that pro-inflammatory genes, cytokines, and chemokines were overexpressed through the TLR signaling 
pathway, leading to chronic inflammation in aged rats. We describe the expression concentration of genes related to TLR signaling pathway 
in Figure S1 and Table S5.
Table 1: Genes in pathways significantly changed by the aging process
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cancer [27]. Arachidonic acid is metabolized to produce 
eicosanoids (prostaglandins (PG), leukotrienes (LT), 
prostacyclins) as inflammatory mediators. 
We observed that the expression levels of enzymes 
related to prostaglandin, leukotriene, and thromboxane 
were significantly changed during aging (Figure S2). 
Expression of PGH2 synthase 1 (PTGS1, also known 
as COX-1), which plays a role in the synthesis of 
PGH2, leading to improper inflammation states and 
hypertension during aging, was up-regulated in aged rats 
by 1.7-fold. Additionally, TBXAS1, which is involved 
in the synthesis of thromboxane A2 (TXA2), was up-
regulated by 2.1-fold in the aged animals. TXA2 is mainly 
produced in the platelets and elicits diverse physiological 
and pathophysiological reactions, including platelet 
aggregation and vascular smooth muscle contraction [28]. 
The expression of enzymes related to the 
biosynthesis of the leukotriene family of proteins was also 
altered in the aged animals. 5-Lipoxygenase (ALOX5, 
known as 5-LO), which plays a role in the synthesis of 
leukotriene A4 (LTA4), was up-regulated by more than 
6.3-fold with age. In contrast, gamma glutamyl transferase 
1 (GGT1) and dipeptidase 1 (DPEP1) genes, which are 
involved in the synthesis of leukotriene E4, were down-
regulated by 2.0-fold and 1.3-fold respectively. We 
described the expression of genes related to arachidonic 
acid metabolism in Table S5.
Figure 4: Genomic position and structure of novel genes related to inflammation. From 322 novel gene candidates that had at 
least one homologous gene in the NR database, we found that only 32 contained functional domains. Among the 32 genes, five possessed 
inflammation-related domains such as the T-cell receptor domain, chemokine domain, and AIM2-related domain. All the gene candidates had 
significant P values (P = 1.4 × 10-5, Fisher’s exact test) in the frequency of inflammation-related genes. We found that XLOC_013124 (5.9-
fold increase), which is assigned as an AIM2-realted domain, was similar to the exons of the mouse AIM2 gene. However, XLOC_013124 
showed variation in the number of exons compared to the mouse AIM2 gene based on our findings. XLOC_031572, XLOC_031585, 
and XLOC_032636 have T-cell receptor related domains. XLOC_043329 (8.9-fold increase) has a domain of chemokiner2 which is C-C 
chemokine receptor type 2 signature. In the figure, red color means novel gene.
Oncotarget30043www.impactjournals.com/oncotarget
Down-regulation of PPARs signaling in kidney
Our analysis detected a change in PPARs and target 
gene expression. PPARs are important transcription 
factors to the regulation of several genes involved in lipid 
metabolism, and they become dis-regulated during aging. 
In this study, we found that lipoprotein lipase (LPL) was 
increased by 1.5-fold, while PPARα, PPARδ, carnitine 
palmitoyltransferase 1 (CPT1), and β-oxidation related 
genes were decreased with aging by 1.5-, 1.9-, and 1.4- 
fold, respectively, compared to young kidneys.
LPL catalyzes the hydrolysis of the triacylglycerol 
component of circulating chylomicrons and very low-
density lipoproteins, thereby providing non-esterified 
fatty acids and 2-monoacylglycerol for tissue utilization 
[29]. Increased renal LPL suggests the possibility of lipid 
accumulation and lipotoxicity in the kidney with aging. 
This may be an important mechanism in the development 
of renal injury associated with metabolic syndrome. CPT 
is located in the mitochondrial membranes, and functions 
to translocate free fatty acids into the mitochondria. 
Therefore, through increasing LPL and decreasing 
mitochondrial β-oxidation resulting from decreased 
PPARα levels, increased uptake of fatty acids into the 
kidneys may occur during aging. Our data support that 
altered lipid metabolism caused by an imbalance between 
lipogenesis and lipolysis induces subsequent renal lipid 
accumulation and renal injury [30]. We described the 
expression concentration of genes related to PPAR 
signaling in Table S5.
Figure 5: Real-time PCR analysis of genes changed in the aging process. We confirmed 23 known genes (14 up-regulated 
genes and 9 down-regulated genes) using real-time PCR. The genes were selected by expression values and the function for those related 
to inflammation and metabolism. Among up-regulated genes, arachidonic acid metabolism (ALOX5, ALOX15B, GPX2, and PTGIS), cell 
adhesion (SIGLEC10), chemokine (CCL21, CXCL2, and CXCL5), interleukin (IL19 and IL1R2), T-cell signaling (FYB), Toll-like receptor 
(TLR7), and tumor necrosis factor (TNFSF8 and TNFSF11) genes were tested for expression levels during aging. In contrast, genes relating 
to amino acid metabolism (AFMID, ALDH1B1, CNDP1, GRHPR, and MDH2), drug metabolism (GSTA2, GSTP1, and UGT2B15), and 
fatty acid metabolism (EHHADH) were tested for down-regulation. We found that the value of fold-change according to RNA-Seq was 
consistent with the results of real-time PCR analysis during aging (Pearson’s correlation = 0.71). Detailed information is described Table 
S1.
Table 2: Inflammation-related genes with alternative splicing events
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New gene candidates identified by DEGs
cDNA microarray technologies cannot detect novel 
genes on the genomic scale. Because the discovery of new 
genes is important in aging research, we utilized RNA-
Seq data and analyses to identify novel genes that were 
significantly changed with age. To predict the function 
of novel genes, we carefully analyzed their sequences 
using the NCBI NT and domain database after removing 
noncoding RNA. From 322 novel gene candidates that 
had at least one homologous gene in the NR database, 
we found that only 32 contained functional domains. The 
genes were differentially expressed by more than 2-fold 
between young and old rats with age. Among the 32 genes, 
five possessed inflammation-related domains such as the 
T-cell receptor domain, chemokine domain, and AIM2-
related domain (Figure 4). All the gene candidates had 
significant P values (P = 1.4 × 10-5, Fisher’s exact test) 
in the frequency of inflammation-related genes. AIM2 
is a main component of the inflammasome, which is 
responsible for activating inflammatory processes [31]. 
We found that XLOC_013124 (5.9-fold increase), which 
is assigned as an AIM2-realted domain, was similar to the 
exons of the mouse AIM2 gene. However, XLOC_013124 
showed variation in the number of exons compared to the 
mouse AIM2 gene based on our findings (Figure 4).
Identification of alternative splicing events during 
the aging process
Using the Cufflink program, we identified 31,506 
known transcripts and 18,119 novel isoforms of known 
transcripts that occur during aging. This result is similar 
to the number of novel isoforms previously reported 
during cell differentiation in mice [19]. To compare the 
transcripts produced by young and old rats, we selected 
107 genes that underwent alternative splicing events and 
were differentially changed by 2-fold or more.
Among the genes with alternative splicing events, 
seven genes were specifically related to inflammation 
(6.5%). Genes related to inflammation included CCL20, 
CCR1, CD44, FGG, CXCR3, IL1RN, FCGR2, and 
NFKBIZ, which were classified as ‘inflammation response’ 
genes according to GO categories (Table 2). To evaluate 
the effect of inflammation on alternative splicing events, 
we tested the statistical significance of inflammation-
related genes that had alternative splicing events. In 
alternative splicing events, the frequency of inflammation-
related genes was significant (P = 3.3 × 10-4, Fisher’s exact 
test), which was similar to known and novel genes.
Real-time PCR results of genes changed by aging 
To confirm aged-related gene expression of RNA-
Seq data, we performed real-time PCR for 23 known 
genes (14 up-regulated and nine down-regulated genes). 
The genes were selected based on their expression values 
or function related to inflammation or metabolism. Among 
Figure 6: Proposed common transcription factors linking inflammation and cancer in the aging process. To identify 
regulatory molecules of up-regulated genes obtained from the gene set enrichment test, we conducted transcription factor analysis using 
the TRANSFAC database. We found that 84 transcription factors existed at the transcriptional start site of up-regulated genes. The current 
transcription factor analysis showed that transcription factors of up-regulated genes can regulate genes related to both inflammation and 
cancer. The transcription factors included well-known cancer-related factors such as EGR1, FOSL1, HIF1A, JUND, NFKB2, and STATs. 
These transcription factors may play major roles to link cancer and inflammatory aging, and they may be target molecules to research the 
correlation between cancer and aging. Detailed information is described in Table S4.
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up-regulated genes, the expression of arachidonic acid 
metabolism (ALOX5, ALOX15B, GPX2, and PTGIS), cell 
adhesion (SIGLEC10), chemokine (CCL21, CXCL2, and 
CXCL5), interleukin (IL19 and IL1R2), T-cell signaling 
(FYB), Toll-like receptor (TLR7), and tumor necrosis 
factor (TNFSF8 and TNFSF11) were evaluated in young 
and old animals. In contrast, genes relating to amino 
acid metabolism (AFMID, ALDH1B1, CNDP1, GRHPR, 
and MDH2), drug metabolism (GSTA2, GSTP1, and 
UGT2B15), and fatty acid metabolism (EHHADH) were 
tested for down-regulation (Figure 5). Statistical relevance 
was calculated by Mann-Whitney test. Also, we found that 
the values for fold-change according to RNA-Seq were 
consistent with the results of real-time PCR for the old 
animals. (Pearson’s correlation = 0.71, Table S1). 
DISCUSSION
Various cDNA microarray studies have been 
conducted with limited results to understand aging and 
they are limited due to the cross-hybridization of probes 
and measurement of only the relative abundances of 
transcripts [32]. RNA-Seq is effective in acquiring short 
but high quality RNA reads [33].
Our RNA-Seq analysis successfully detected the up-
regulation of inflammation-related gene candidates that 
are probably involved in aging. A number of statistically 
significant (P < 0.001) novel genes and alternative splicing 
events related to inflammation were also detected. In spite 
of that the results of RNA-Seq should be confirmed by 
complicated experiments, we showed that inflammation 
alters gene expression, including expression of previously 
novel genes and alternative splicing events in the 
transcriptome of aged rats, 
Inflammation was activated through the up-
regulation of genes involved in various pathways, such 
as cytokines, T- and B-cell signaling, TLR signaling, and 
arachidonic acid metabolism in aged rats although our 
RNA-Seq analyses are limited and cannot pin-point the 
causal genes with proper mechanism understanding. This 
is the limitation of large scale sequencing based analyses. 
Arachidonic acid metabolism plays important roles 
in inflammation and cancer. Changes in eicosanoid-
forming enzymes during aging showed interesting results 
in our experiments. Up-regulation of COX-1 (1.7-fold) 
indicated that the key enzyme in PGH2 synthesis is 
dysregulated during aging. Increased TBXAX1 (2.0-fold) 
may induce synthesis of TXA2, which causes changes 
in platelet shape, aggregation, and secretion, thereby 
promoting thrombus formation and thrombosis [28]. 
Several publications report on the overexpression of TXA2 
in aging [34] and several cardiovascular diseases [35]. 
ALOX5, which converts arachidonic acid to LTA4, also 
plays various roles in physiological or pathophysiological 
conditions [36]. LTA4 is further changed into LTB4 by 
LTA4 hydroxylase. LTB4 is related to many inflammatory 
diseases, such as asthma, inflammatory bowel diseases, 
atherosclerosis, and nephritis [37]. Despite its importance 
in inflammation, changes in LT synthase enzymes such 
as ALOX5 with aging were relatively negligible. We 
observed that ALOX5 gene expression levels were up-
regulated in aged kidneys, implying that this up-regulation 
may aggravate age-related kidney dysfunction.
PPARs are ligand-activated transcription factors 
belonging to the nuclear receptor superfamily. Although 
PPAR involvement was thought to be limited to lipid 
metabolism and glucose homeostasis, recent studies show 
that PPARs are also important in aging processes and 
age-related inflammation. PPARα has been demonstrated 
to play an important role in regulating the CPT gene. 
Reduced PPARα expression down-regulates CPT2 gene 
expression, leading to renal lipid accumulation. Previous 
studies have shown that age-associated declines in PPARα 
expression and function occur in a variety of tissues, 
including the kidney. Similarly, the expression of several 
genes encoding β-oxidation enzymes, which are regulated 
by PPARα, is also shown to be reduced as a consequence 
of aging. Our data are in agreement with previously 
published data obtained with the down-regulation of 
PPARα levels in RNA-Seq data. Reduction of PPARα with 
aging may be related to the observed aging-associated 
effects on lipid metabolism and fatty acid oxidation 
activity in the kidney. 
This current transcription factor analysis showed that 
transcription factors of up-regulated genes can regulate 
genes related to both inflammation and cancer. The 
transcription factors included well-known cancer-related 
factors such as EGR1, FOSL1, HIF1A, JUND, NFKB2, 
and STATs. These results indicate that transcription factors 
are important links between cancer and the inflammatory 
aging process, and are good target molecules in identifying 
the correlation between cancer and aging, as depicted in 
Figure 6.
In summary, we conducted a large scale RNA-Seq to 
obtain highly accurate transcriptome data, which is useful 
for exploring complex pathophysiological phenomena 
such as aging. The RNA-Seq data and analyses enabled us 
to identify transcriptome changes, including novel genes 
and alterative splicing forms altered by aging. We also 
speculate that RNA-Seq data is useful to detect candidate 
markers and can be used as diagnostics to provide 
continuous monitoring of pathology related to aging. 
MATERIALS AND METHODS
Sample preparation for Illumina Hiseq2000 
sequencing
Young (6-month-old) and old (25-month-old) 
specific pathogen-free male Sprague-Dawley rats 
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were obtained from Samtako, Inc. (Osan, Korea). Rat 
maintenance procedures for specific pathogen-free status 
and dietary composition of chow have been previously 
reported [19, 38]. The cortex of kidney tissues from the 
six SD rats was removed for RNA extraction. Rats were 
sacrificed by decapitation and the kidneys were quickly 
removed and immediately frozen in liquid nitrogen 
and stored at -80°C. Total RNA was isolated from the 
cortex of kidney sample using the miRNeasy Mini Kit 
(Qiagen, Hilden, Germany). An RNA sequencing library 
was generated using TruSeq RNA sample preparation 
Kit according to user’s instruction manual (Illumina, 
San Diego, CA, USA). Briefly, mRNA was separated 
from total RNA using Oligo(dT) beads and chemically 
fragmented. After double-strand cDNA synthesis of the 
fragmented mRNA, end-repair, adenylation of 3′-end, and 
sequencing adapter ligation were performed, followed 
by DNA purification with magnetic beads and PCR 
amplification. Finally, the amplified library was purified, 
quantified, and then applied for template preparation. The 
HiSeq2000 platform was utilized to generate 99-bp paired-
end sequencing reads (Illumina).
Genome mapping and identification of paired-end 
sequences 
All 99-bp paired-end sequence reads were mapped 
to the rat genome (NCBI build 5) using TopHat version 
2.0.4. These mapped reads were merged for each condition 
(young vs old), and transfrags were assembled using 
Cufflink version 2.0.1. These merged transfrags were 
quantified for each condition using the Cuffdiff program. 
Finally, we identified differentially expressed genes, novel 
alternative splicing isoforms, and novel expression of 
transcript candidates.
Gene set enrichment test
To characterize the biological pathways related 
to differentially expressed sequences and transcription 
factors, representative pathways were analyzed in the 
context of several databases such as KEGG (http://www.
genome.ad.jp), BioCarta (http://www.biocarta.com), and 
Reactome (http://www.reactome.org), as suggested by 
MsigDB v4.0 [20]. The pathway terminologies are listed 
in MsigDB. Additionally, we used Fisher’s exact test and 
FDR to examine mapping pathways (filtering options: 
P < 0.01 and FDR < 5). FDR was calculated by q-value 
package of R program. We developed a modified gene 
set enrichment test to obtain the p-value of the gene set 
involving transcription factors that existed in the TSS 
of up-regulated inflammatory gene. Because number of 
transaction factors in a pathway were smaller than other 
proteins, we multiplied the gene set of transcription factors 
(Pgsea(TF)) by gene set of total differentially expressed 
genes ((Pgsea(DEGtotal)). PTF indicates the modified p-value 
that was calculated using the following equation:
Gene ontology analysis and functional annotation
To identify inflammation-related genes, we used 
GO terms, which are part of an international standardized 
gene functional classification system. The GO annotations 
of each gene were obtained from gene2go, which is a 
part of the NCBI Entrez database. We regarded genes 
with ‘inflammation response’ in the GO term as the 
inflammation-related genes. To determine the function of 
novel genes, we aligned our sequences with the nucleotide 
databases of NT (filtering option: e-value < 0.0001) using 
BLAST. The gene showing the highest sequence similarity 
in each BLAST result was chosen to annotate the function 
of the query gene. From novel genes, which were assigned 
to the NCBI NT database, we removed non-coding RNA 
using BLAST alignment tool using Rfam database [39] 
(filtering option: e-value < 0.0001). To predict whether a 
functional domain existed in novel genes, we also used 
InterProScan version 5 with a filtering option of P < 1 × 
10-4 [40]. 
Quantitative RT-PCR
Total RNA from the tissues was isolated using 
a rapid extraction method (TRI-Reagent, Invitrogen, 
Carlsbad, CA, USA). Real-time PCR was performed on 
cDNA samples using the iQTM SYBR Green Supermix 
system (Bio-Rad, Hercules, CA, USA). Primers are 
described in Table S1. The protocols used are as follows: 
denaturation (95°C for 2 min), amplification repeated 40 
times (95°C for 15 s, 55°C for 30 s, 72°C for 30 s, and 
acquisition temperature for 15 s) (Bioneer ExicycleTM 
96, Daejeon, Korea). Analysis was conducted using the 
sequence detection software supplied with the instrument. 
For each sample, the delta delta Threshold Cycle (ddCT) 
(crossing point) values were calculated as the Ct of the 
target gene minus the Ct of the GAPDH gene. Gene 
expression was derived according to the equation 2–ddCt; 
changes in gene expression are expressed relative to basal 
levels.
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